ACTRN12622000953730
Not yet recruiting
未知
Artificial Intelligence and mHealth to Determine the response to a LIfestyle intervention for the primary prevention of Osteoporosis and frailty fractures in Postmenopausal women
niversity of Seville0 sites114 target enrollmentJuly 6, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Osteoporosis
- Sponsor
- niversity of Seville
- Enrollment
- 114
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria
- •\- Postmenopausal women older than 40 years with greater than 8 years after menopause (early postmenopausal women”).
- •\- Sedentary women (defined as not performing regular physical activity greater than 150 min of moderate\-vigorous physical activity per week in the last six months).
- •\- Willing to give consent to participate in the study.
Exclusion Criteria
- •Exclusion criteria
- •\- Surgically induced menopause or cancer treatment.
- •\- Low BMI (\<18 kg / m2\).
- •\- Excessive alcohol consumption (greater than 3 drinks per day).
- •\- Unstable cardiovascular disease.
- •\- Rheumatoid arthritis.
- •\- Chronic kidney disease
- •\- Diagnosis of conditions that alter bone metabolism (hypo/hypercalcemia, hyperthyroidism, hypo/hypergonadism).
- •\- Upper or lower limb fracture in the last 6 months.
- •\- Mobility problems or requiring assistance to walk.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
2PCubeHealth project for early detection of CancerHealth Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C069- Malignant neoplasm of mouth, unspecifiedHealth Condition 3: C029- Malignant neoplasm of tongue, unspecifiedCTRI/2024/02/062417Dr Krishna Dev Kumar
Not yet recruiting
Not Applicable
Construction of artificial intelligence health management platform based on dysfunction of Shaoyang for the treatment of metabolic syndrome and prevention of ischemic cerebrovascular disease.ITMCTR2000003286Shanghai Sixth People's Hospital
Not yet recruiting
Not Applicable
Artificial intelligence and smart application for diagnosis of pediatric skin diseasesAcne vulgaris, Atopic dermatitis, Seborrheic dermatitis, Irritant contact dermatitis, Psoriasis vulgaris, Xerosis cutis, Vitiligo, Cafe au lait spots, Melanocytic nevi, Congenital non-neoplastic nevusArtificial intelligence, pediatric skin diseasesTCTR20210816003Office of the National Digital Economy and Society Commission500
Not yet recruiting
Not Applicable
se of AI in Cardiovascular Risk Prediction.Health Condition 1: E116- Type 2 diabetes mellitus with other specified complicationsCTRI/2023/07/054781A
Not yet recruiting
Not Applicable
Development of an Artificial Intelligence (AI) model to predict changes with a removable functional appliance in growing childreCTRI/2024/08/072321Council of Scientific & Industrial Research (CSIR), India